​

Funding Round

Series D - XtalPi

Series D - XtalPi

Investment Firm

Overview

XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.

Announced Date

Aug 11, 2021

Funding Type

Series D

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

OrbiMed

OrbiMed

OrbiMed is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

HOPU Investment

HOPU Investment

HOPU Investment is a late_stage_venture firm.

Participant Investors

4

Investor Name
Participant InvestorHOPU Investment
Participant InvestorTaihill Venture
Participant Investor5Y Capital
Participant InvestorOrbiMed

Round Details and Background

XtalPi raised $400000000 on 2021-08-11 in Series D

XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 13, 2019
Series B - XtalPi
1-undefined
Sep 28, 2020
Series C - XtalPi
14-318.8M
Aug 11, 2021
Series D - XtalPi
6-400.0M
Jul 01, 2021
Series C - XtalPi
1-undefined

Recent Activity

There is no recent news or activity for this profile.